Samsung Biologics
207940.KS
#396
Rank
NZ$86.17 B
Marketcap
$1,211
Share price
-0.57%
Change (1 day)
24.68%
Change (1 year)

EPS for Samsung Biologics (207940.KS)

EPS in 2023 (TTM): $14.47

According to Samsung Biologics 's latest financial reports the company's current EPS (TTM) is $14.94. In 2022 the company made an earnings per share (EPS) of $14.93 an increase over its 2021 EPS that were of $8.47.

EPS history for Samsung Biologics from 2016 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$14.47-3.08%
2022$14.9376.23%
2021$8.4761.48%
2020$5.2521.05%
2019$4.33-12.56%
2018$4.96-330.46%
2017-$2.15-51.86%
2016-$4.47